AnalystsSean Laaman
Sean Laaman's Stock Forecasts

Analyst Ranking
Top 24%
#1288 out of 5342 analysts
Average Return
+14.1%
Win Rate
73%19 out of 26
Risk vs Reward
Poor
Good

Sean Laaman's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Resmed IncRMD
+90.17%$134.65$256.07
2023-10-27 -
2024-10-25
Strong Buy
Beone Medicines LtdONC
+60.28%$206.01$330.19
2024-12-03 -
2025-12-02
Strong Buy
Axsome Therapeutics IncAXSM
+58.91%$105.44$167.55
2025-07-03 -
2026-01-08
Strong Buy
Disc Medicine IncIRON
+39.29%$54.75$76.26
2025-07-03 -
2026-07-02
Strong Buy
Halozyme Therapeutics IncHALO
+36.28%$58.29$79.44
2025-02-14 -
2026-02-13
Strong Buy

Sean Laaman's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Maplight Therapeutics IncMPLT
2Hold$21.00+62.29%Downgrades
9 days ago
Exelixis IncEXEL
8Hold$53.00-5.36%Maintains
13 days ago
Erasca IncERAS
1Hold$21.00+14.25%Maintains
17 days ago
Disc Medicine IncIRON
5Strong Buy$85.00+9.25%Maintains
2 months ago
Generate Biomedicines IncGENB
2Strong Buy$22.00+54.06%Maintains
3 months ago
Certara IncCERT
3Hold$10.00+28.21%Maintains
3 months ago
Axsome Therapeutics IncAXSM
5Hold$242.00+14.06%Maintains
3 months ago
Eikon Therapeutics IncEIKN
1Strong Buy$32.00+234.73%Initiates Coverage On
5 months ago
Bridgebio Pharma IncBBIO
2Strong Buy$98.00+19.41%Maintains
5 months ago
Bridgebio Oncology Therapeutics IncBBOT
1Strong Buy$20.00+125.48%Initiates Coverage On
8 months ago
Resmed IncRMD
2Strong Buy$304.00+36.24%Maintains
10 months ago
Beone Medicines LtdONC
3Strong Buy$383.00+18.57%Maintains
10 months ago
Alector IncALEC
1Strong Sell$1.50N/AAssumes
a year ago
Halozyme Therapeutics IncHALO
1Strong Buy$67.00N/AAssumes
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.